[1]
Wani, I.Y., Saleem, S. and Mehraj, I. 2021. Lisinopril as a prophylactic agent for migraine: a randomised double blind placebo controlled cross over prospective study in Kashmir. International Journal of Advances in Medicine. 8, 4 (Mar. 2021), 536–540. DOI:https://doi.org/10.18203/2349-3933.ijam20211051.